Back to 
BlackRock, Inc.
BlackRock, Inc.
BCRX7 quarters
Position history for BlackRock, Inc.'s holdings in BIOCRYST PHARMACEUTICALS INC
BlackRock, Inc. holds 23.9M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $238.9M as of 2026-Q2. The position was increased (+5.5% shares). BCRX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$238.9M
Current Shares
23.9M
Total Value Change
+$72.8M
Total Shares Change
+1.8M
Quarter-by-Quarter History
Other major holders of BCRX: BNP PARIBAS FINANCIAL MARKETS, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC